^
BIOMARKER:

HYAL4 V1

i
Other names: Hyaluronidase 4, Chondroitin Sulfate Endo-Beta-N-Acetylgalactosaminidase, Chondroitin Sulfate Hydrolase, Hyaluronoglucosaminidase 4, Hyaluronidase-4, CSHY, Hyaluronoglucosaminidase-4, HYAL-4 Variant 1, HYAL-4, Hyal-4, HYAL4
Entrez ID:
2ms
V1 drives Gemcitabine resistance and potentially predicts G+C failure. Combination with Tetrahydrouridine overcomes Gemcitabine resistance. Since Gemcitabine is included in several chemotherapy regimens, our study could have broad significance.
Clinical
|
HYAL4 (Hyaluronidase 4)
|
HYAL4 V1
|
cisplatin • gemcitabine